Works matching IS 13518216 AND DT 2004 AND VI 10 AND IP 5

Results: 33

HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg593 to Cys mutation.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 509, doi. 10.1111/j.1365-2516.2004.01011.x
By:
- Bril, W. S.;
- P. E. Maclean;
- P. H. P. Kaijen;
- van den Brink, E. N.;
- Lardy, N. M.;
- K. Fijnvandraat;
- M. Peters;
- Voorberg, J.
Publication type:
Article
Severe factor X deficiency in pregnancy: case report and review of the literature.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 665, doi. 10.1111/j.1365-2516.2004.01012.x
By:
- Romagnolo, C.;
- Burati, S.;
- Ciaffoni, S.;
- Fattori, E.;
- Franchi, M.;
- Zanon, E.;
- Girolami, A.
Publication type:
Article
Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 452, doi. 10.1111/j.1365-2516.2004.01013.x
By:
- Stieltjes, N.;
- Altisent, C.;
- Auerswald, G.;
- Négrier, C.;
- Pouzol, P.;
- Reynaud, J.;
- Roussel-Robert, V.;
- Savidge, G. F.;
- Villar, A.;
- Schulman, S.
Publication type:
Article
Successful use of ReFacto continuous infusion in two paediatric patients with severe haemophilia A undergoing orthopaedic surgery.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 655, doi. 10.1111/j.1365-2516.2004.00905.x
By:
- Sennett, M. M.;
- de Alarcón, P. A.
Publication type:
Article
Haemostatic management of intraoral bleeding in patients with congenital deficiency ofα2-plasmin inhibitor or plasminogen activator inhibitor-1.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 669, doi. 10.1111/j.1365-2516.2004.00914.x
By:
- Morimoto, Y.;
- Yoshioka, A.;
- Imai, Y.;
- Takahashi, Y.;
- Minowa, H.;
- Kirita, T.
Publication type:
Article
Functional consequences of haemophilia in adults: the development of the Haemophilia Activities List.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 565, doi. 10.1111/j.1365-2516.2004.01016.x
By:
- van Genderen, F. R.;
- van Meeteren, N. L. U.;
- van der Bom, J. G.;
- Heijnen, L.;
- de Kleijn, P.;
- van den Berg, H. M.;
- Helders, P. J. M.
Publication type:
Article
Acquired inhibitor of factor V: first report in China and literature review.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 661, doi. 10.1111/j.1365-2516.2004.01014.x
By:
- Lu, L.;
- Liu, Y.;
- Wei, J.;
- Zhang, L.;
- Yang, R.
Publication type:
Article
Factors which may influence coping with disease in haemophilia patients.
Published in:
2004
By:
- Canclini, M.;
- Zanon, E.;
- Girolami, A.
Publication type:
Letter
Informativeness of linkage analysis for genetic diagnosis of haemophilia A in India.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 553, doi. 10.1111/j.1365-2516.2004.00908.x
By:
- Jayandharan, G.;
- Shaji, R. V.;
- George, B.;
- Chandy, M.;
- Srivastava, A.
Publication type:
Article
Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate®): a prospective pharmacovigilance study.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 491, doi. 10.1111/j.1365-2516.2004.00904.x
By:
- Ewenstein, B. M.;
- Gomperts, E. D.;
- Pearson, S.;
- O'Banion, M. E.
Publication type:
Article
Yttrium.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 590, doi. 10.1111/j.1365-2516.2004.01035.x
By:
- Helm, M.;
- Tiktinsky, R.;
- Amit, Y.;
- Martinowitz, U.
Publication type:
Article
Radiation synovectomy by188Re-Sulfide in haemophilic synovitis.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 422, doi. 10.1111/j.1365-2516.2004.00913.x
By:
- Li, P.;
- Chen, G.;
- Zhang, H.;
- Shen, Z.
Publication type:
Article
Endometrial ablation for von Willebrand disease-related menorrhagia– experience with seven cases.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 477, doi. 10.1111/j.1365-2516.2004.00915.x
By:
- Rubin, G.;
- Wortmant, M.;
- Kouides, P. A.
Publication type:
Article
Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 413, doi. 10.1111/j.1365-2516.2004.00919.x
By:
- Theodore, D.;
- Fried, M. W.;
- Kleiner, D. E.;
- Kroner, B. L.;
- Goedert, J. J.;
- Eyster, M. E.;
- Faust, S. P.;
- Sherman, K. E.;
- Kessler, C. M.;
- Francis, C.;
- Aledort, L. M.
Publication type:
Article
Shoulder hemiarthroplasty to manage haemophilic arthropathy: two case studies.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 649, doi. 10.1111/j.1365-2516.2004.00923.x
By:
- Dalzell, R.
Publication type:
Article
Survival analysis of patients with haemophilia at the International Haemophilia Training Centre, Bangkok, Thailand.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 542, doi. 10.1111/j.1365-2516.2004.00928.x
By:
- Chuansumrit, A.;
- Krasaesub, S.;
- Angchaisuksiri, P.;
- Hathirat, P.;
- Isarangkura, P.
Publication type:
Article
Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 572, doi. 10.1111/j.1365-2516.2004.00930.x
By:
- Magli-Barioz, D.;
- Ounnoughène, N.;
- Paugy, P.;
- Quarrè, M.-C.;
- Vassilief, D.;
- Lopez, I.;
- Goudemand, J.;
- Negrier, C.;
- Assogba, U.;
- Driss, F.;
- A.-Dumont, M.;
- Molho, P.
Publication type:
Article
Increased breakthrough bleeding during prophylaxis with B-domain deleted factor VIII– a robust meta-analytic finding.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 449, doi. 10.1111/j.1365-2516.2004.00931.x
By:
- Gruppo, R. A;
- Brown, D.;
- Wilkes, M. M.;
- Navickis, R. J.
Publication type:
Article
Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 428, doi. 10.1111/j.1365-2516.2004.00932.x
By:
- Tarantino, M. D.;
- Collins, P. W.;
- Hay, C. R. M.;
- Shapiro, A. D.;
- Gruppo, R. A.;
- Berntorp, E.;
- Bray, G. L.;
- Tonetta, S. A.;
- Schroth, P. C.;
- Retzios, A. D.;
- Rogy, S. S.;
- Sensel, M. G.;
- Ewenstein, B. M.
Publication type:
Article
Consensus recommendations for use of central venous access devices in haemophilia.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 629, doi. 10.1111/j.1365-2516.2004.00943.x
By:
- Ewenstein, B. M.;
- Valentino, L. A.;
- Journeycake, J. M.;
- Tarantino, M. D.;
- Shapiro, A. D.;
- Blanchette, V. S.;
- Hoots, W. K.;
- Buchanan, G. R.;
- Manco-Johnson, M. J.;
- Rivard, G. -E.;
- Miller, K. L.;
- Geraghty, S.;
- Maahs, J. A.;
- Stuart, R.;
- Dunham, T.;
- Navickis, R. J.
Publication type:
Article
The rare coagulation disorders– review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 593, doi. 10.1111/j.1365-2516.2004.00944.x
By:
- Bolton-Maggs, P. H. B.;
- Perry, D. J.;
- Chalmers, E. A.;
- Parapia, L. A.;
- Wilde, J. T.;
- Williams, M. D.;
- Collins, P. W.;
- Kitchen, S.;
- Dolan, G.;
- Mumford, A. D.
Publication type:
Article
Clinical manifestations and management of labor and delivery in women with factor IX deficiency.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 483, doi. 10.1111/j.1365-2516.2004.00946.x
By:
- Yang, M. Y.;
- Ragni, M. V.
Publication type:
Article
Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin® SDH in previously treated patients with severe haemophilia A.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 438, doi. 10.1111/j.1365-2516.2004.00947.x
By:
- Wolf, D. M.;
- Rokicka-Milewska, R.;
- Lopaciuk, S.;
- Skotnicki, A. B.;
- Klukowska, A.;
- Laguna, P.;
- Windyga, J.;
- Kotitschke, R.;
- Struff, W. G.
Publication type:
Article
Novel missense mutation in the coagulation factor IX catalytic domain associated with severe haemophilia B– Factor IXDelhi.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 550, doi. 10.1111/j.1365-2516.2004.00948.x
By:
- Mahajan, A.;
- Sharma, A.;
- Chavali, S.;
- Kabra, M.;
- Chowdhury, M. R.;
- Srinivasan, N.;
- D. Bharadwaj
Publication type:
Article
Comparative effectiveness of plasma-derived and recombinant FVIII concentrates in the on-demand and prophylactic treatment of patients with haemophilia A.
Published in:
2004
By:
- Pollmann, H.;
- Richter, H.;
- Siegmund, B.
Publication type:
Letter
Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 499, doi. 10.1111/j.1365-2516.2004.00950.x
By:
- Auerswald, G.;
- Prondzinski, M. Von Depka;
- Ehlken, B.;
- Kreuz, W.;
- Kurnik, K.;
- Lenk, H.;
- Scharrer, I.;
- Schramm, W.;
- Zimmermann, R.
Publication type:
Article
Factor XIII deficiency in south-east Iran.
Published in:
2004
By:
- Eshghi, P.;
- Abolghasemi, H.;
- Sanei-Moghaddam, E.;
- Anwar, R.;
- Jazebi, M.;
- Amid, A.;
- Alatt, F. A.
Publication type:
Letter
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 515, doi. 10.1111/j.1365-2516.2004.00952.x
By:
- Carlsson, K. Steen;
- Höjgard, S.;
- Lindgren, A.;
- Lethagen, S.;
- Schulman, S.;
- Glomstein, A.;
- Tengborn, L.;
- Berntorp, E.;
- Lindgren, B.
Publication type:
Article
Type 2N von Willebrand disease mutations in Brazilian individuals.
Published in:
2004
By:
- Simon, D.;
- Roisenberg, I.
Publication type:
Letter
Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 527, doi. 10.1111/j.1365-2516.2004.00954.x
By:
- Carlsson, K. Steen;
- Höjgård, S.;
- Lethagen, S.;
- Lindgren, A.;
- Berntorp, E.;
- Lindgren, B.
Publication type:
Article
The impact of unaware carriership on the clinical presentation of haemophilia.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 560, doi. 10.1111/j.1365-2516.2004.00955.x
By:
- MaClean, P. E.;
- Fijnvandraat, K.;
- Beijlevelt, M.;
- Peters, M.
Publication type:
Article
Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 459, doi. 10.1111/j.1365-2516.2004.00957.x
By:
- Lin, Y.;
- Yang, X.;
- Chevrier, M. -C.;
- Craven, S.;
- Barrowcliffe, T. W.;
- Lemieux, R.;
- Ofosu, F. A.
Publication type:
Article
Asking fathers: a study of psychosocial adaptation.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 582, doi. 10.1111/j.1365-2516.2004.00958.x
By:
- Herrick, E. K.;
- Nussbaum, R.;
- Holtzman, N. A.;
- Wissow, L.
Publication type:
Article

Works matching IS 13518216 AND DT 2004 AND VI 10 AND IP 5

HLA class II genotype and factor VIII inhibitors in mild haemophilia A patients with an Arg<sup>593</sup> to Cys mutation.

Severe factor X deficiency in pregnancy: case report and review of the literature.

Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: clinical experience.

Successful use of ReFacto continuous infusion in two paediatric patients with severe haemophilia A undergoing orthopaedic surgery.

Haemostatic management of intraoral bleeding in patients with congenital deficiency ofα2-plasmin inhibitor or plasminogen activator inhibitor-1.

Functional consequences of haemophilia in adults: the development of the Haemophilia Activities List.

Acquired inhibitor of factor V: first report in China and literature review.

Factors which may influence coping with disease in haemophilia patients.

Informativeness of linkage analysis for genetic diagnosis of haemophilia A in India.

Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate<sup>®</sup>): a prospective pharmacovigilance study.

Yttrium.

Radiation synovectomy by<sup>188</sup>Re-Sulfide in haemophilic synovitis.

Endometrial ablation for von Willebrand disease-related menorrhagia– experience with seven cases.

Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C.

Shoulder hemiarthroplasty to manage haemophilic arthropathy: two case studies.

Survival analysis of patients with haemophilia at the International Haemophilia Training Centre, Bangkok, Thailand.

Evaluation of the impact of information about treatment-related risks in patients receiving blood-derived or recombinant medications.

Increased breakthrough bleeding during prophylaxis with B-domain deleted factor VIII– a robust meta-analytic finding.

Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A.

Consensus recommendations for use of central venous access devices in haemophilia.

The rare coagulation disorders– review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation.

Clinical manifestations and management of labor and delivery in women with factor IX deficiency.

Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin<sup>®</sup> SDH in previously treated patients with severe haemophilia A.

Novel missense mutation in the coagulation factor IX catalytic domain associated with severe haemophilia B– Factor IX<sub>Delhi</sub>.

Comparative effectiveness of plasma-derived and recombinant FVIII concentrates in the on-demand and prophylactic treatment of patients with haemophilia A.

Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany.

Factor XIII deficiency in south-east Iran.

Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.

Type 2N von Willebrand disease mutations in Brazilian individuals.

Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden.

The impact of unaware carriership on the clinical presentation of haemophilia.

Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates.

Asking fathers: a study of psychosocial adaptation.